Pricing Log in Create free account

Crescent Biopharma, Inc. (CBIO) vs Entera Bio Ltd. (ENTX)

Crescent Biopharma, Inc. and Entera Bio Ltd. are both Biotechnology companies. Crescent Biopharma, Inc. and Entera Bio Ltd. are of similar size ($481.5M and $463.6M). Entera Bio Ltd. grew revenue faster over the last twelve months: 66.4% against −45.1%. Across the 13 metrics below, Crescent Biopharma, Inc. leads on 8 and Entera Bio Ltd. on 5.

Valuation

Metric CBIO ENTX Biotechnology median
P/E n/m n/m 8.50
P/S 296.75 606.32 9.71
P/B 2.27 18.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 186.66 541.12 9.21
Earnings yield (56.76%) (13.06%) (33.15%)
Free cash flow yield (19.88%) (8.13%) (25.50%)

Profitability

Metric CBIO ENTX Biotechnology median
Gross margin 19.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (112.14%) (138.92%) (56.36%)
Return on assets (97.08%) (87.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBIO ENTX Biotechnology median
Revenue growth (TTM) (45.09%) 66.42% 6.02%
EPS growth (last fiscal year) 44.97% 0.00% 30.26%
Revenue growth, 5-year CAGR 257.77% (29.19%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBIO ENTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.66 8.98 4.72
Net debt to EBITDA 1.40 1.29 0.96

Dividend

Metric CBIO ENTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CBIO ENTX Biotechnology median
Market cap 463.56m 481.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack